Control Bionics Limited (CBL) ORDINARY FULLY PAID |
Health Care |
$11 |
Notice Pursuant to Section 708A(5)(e)
|
26 Feb 2025 3:26PM |
$0.039 |
$0.037 |
fallen by
5.13%
|
|
Control Bionics Limited (CBL) ORDINARY FULLY PAID |
Health Care |
$11 |
Application for quotation of securities - CBL
|
26 Feb 2025 3:24PM |
$0.039 |
$0.037 |
fallen by
5.13%
|
|
BPH Global Ltd (BP8) ORDINARY FULLY PAID |
Health Care |
$2 |
Application for quotation of securities - BP8
|
26 Feb 2025 3:22PM |
$0.004 |
$0.003 |
fallen by
25%
|
|
Aneka Tambang (Persero) Tbk (Pt) (ATM) CHESS DEPOSITARY INTERESTS 1:5 |
Materials |
$1 |
ANTAM Wins Gold PROPER, Proving Commitment to Sustainability
|
26 Feb 2025 3:22PM |
$0.995 |
$0.995 |
fallen by
0%
|
|
Insurance Australia Group Limited (IAG) ORDINARY FULLY PAID |
Financials |
$18,000 |
IAG prices wholesale subordinated note issue
|
26 Feb 2025 3:22PM |
$7.830 |
$7.610 |
fallen by
2.81%
|
|
Universal Biosensors, Inc. (UBI) CHESS DEPOSITARY INTERESTS 1:1 |
Health Care |
$21 |
FY2024 Annual Results Presentation
|
26 Feb 2025 3:21PM |
$0.074 |
$0.072 |
fallen by
2.70%
|
|
UBI - Price-sensitive ASX Announcement
Full Release
Key Points
- UBI has launched nine market-leading products in the last four years.
- More than 15 billion tests have been delivered globally using UBI's technology.
- Two new products focused on environmental testing are set to launch in H1 2025.
- Xprecia Prime received FDA approval and has seen first sales in the US.
- Revenue from wine testing products has shown significant growth despite challenges.
- AQUASCOUT is a new handheld water testing device for lead and copper detection.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Far East Gold Ltd (FEG) ORDINARY FULLY PAID |
Materials |
$61 |
Change in substantial holding
|
26 Feb 2025 3:18PM |
$0.165 |
$0.165 |
fallen by
0%
|
|
Syntara Limited (SNT) ORDINARY FULLY PAID |
Health Care |
$127 |
Half Year Report and Appendix 4D
|
26 Feb 2025 3:18PM |
$0.082 |
$0.078 |
fallen by
4.88%
|
|
SNT - Price-sensitive ASX Announcement
Full Release
Key Points
- Syntara Limited's half-year report shows a revenue increase of 337.94% to $3,070,000.
- Loss attributable to owners decreased by 54.3% to $2,716,000.
- Focus on lead drug candidate SNT-5505 for myelofibrosis with FDA Orphan Drug Designation.
- Progressing clinical studies for myelodysplastic syndrome and scarring treatments.
- No dividends were paid, recommended, or declared during the current financial period.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Universal Biosensors, Inc. (UBI) CHESS DEPOSITARY INTERESTS 1:1 |
Health Care |
$21 |
FY2024 Appendix 4G and Corporate Governance Statement
|
26 Feb 2025 3:16PM |
$0.074 |
$0.072 |
fallen by
2.70%
|
|
Technology One Limited (TNE) ORDINARY FULLY PAID |
Information Technology |
$9,134 |
Notification regarding unquoted securities - TNE
|
26 Feb 2025 3:16PM |
$31.040 |
$27.900 |
fallen by
10.12%
|
|
Universal Biosensors, Inc. (UBI) CHESS DEPOSITARY INTERESTS 1:1 |
Health Care |
$21 |
Appendix 4E and Annual Report FY2024
|
26 Feb 2025 3:15PM |
$0.074 |
$0.072 |
fallen by
2.70%
|
|
UBI - Price-sensitive ASX Announcement
Full Release
Key Points
- UBI received FDA approval for its Xprecia Prime Coagulation Analyzer.
- The company raised A$10 million through a fully underwritten rights issue.
- UBI is focused on expanding its biosensor technology.
- The company operates under strict regulatory compliance.
- Key products are targeted towards human health, veterinary, and wine industries.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Whitehaven Coal Limited (WHC) ORDINARY FULLY PAID |
Energy |
$4,635 |
Appendix 3Y - Mark Vaile
|
26 Feb 2025 3:13PM |
$5.755 |
$5.540 |
fallen by
3.74%
|
|
Livium Ltd (LIT) ORDINARY FULLY PAID |
Industrials |
$15 |
Proposed issue of securities - LIT
|
26 Feb 2025 3:00PM |
$0.015 |
$0.009 |
fallen by
37.93%
|
|
Gryphon Capital Income Trust (GCI) ORDINARY UNITS FULLY PAID |
Financials |
$843 |
Net Tangible Asset Backing
|
26 Feb 2025 2:58PM |
$2.030 |
$2.010 |
fallen by
0.99%
|
|
Livium Ltd (LIT) ORDINARY FULLY PAID |
Industrials |
$15 |
Update - Proposed issue of securities - LIT
|
26 Feb 2025 2:50PM |
$0.015 |
$0.009 |
fallen by
37.93%
|
|
Charter Hall Group (CHC) STAPLED SECURITIES US PROHIBITED |
Real Estate |
$7,724 |
Fund Payment Notice
|
26 Feb 2025 2:43PM |
$17.320 |
$16.330 |
fallen by
5.72%
|
|
Volt Resources Limited (VRC) ORDINARY FULLY PAID |
Materials |
$20 |
Response to ASX Price and Volume Query
|
26 Feb 2025 2:41PM |
$0.005 |
$0.005 |
fallen by
10%
|
|
VRC - Price-sensitive ASX Announcement
Full Release
Key Points
- Volt Resources is responding to an ASX query about trading price and volume.
- The company's securities increased from $0.003 to $0.005.
- VRC is not aware of any undisclosed information that could explain recent trading.
- Recent news highlights a critical minerals deal between Ukraine and the US.
- The deal is expected to positively impact VRC's operations at Zavalievsky Graphite mine.
- VRC confirms compliance with ASX Listing Rules.
- All responses to ASX queries were authorized by the board.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Growthpoint Properties Australia (GOZ) FULLY PAID ORDINARY/UNITS STAPLED SECURITIES |
Real Estate |
$1,712 |
GOZ fund payment notice (foreign residents)
|
26 Feb 2025 2:38PM |
$2.410 |
$2.270 |
fallen by
5.81%
|
|
Star Combo Pharma Limited (S66) ORDINARY FULLY PAID |
Consumer Staple |
$22 |
S66 Dec 2024 Half Year Report & Financial Statements
|
26 Feb 2025 2:36PM |
$0.185 |
$0.165 |
fallen by
10.81%
|
|
S66 - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue increased by 28% to $15,749,723.
- Operating profit after tax rose by 120% to $276,342.
- Total comprehensive income attributable to shareholders was $261,693, up 154% from the previous year.
- OEM division revenue increased by 50% to $11.29 million.
- Retail sales fell by 28.5% to $1,112,973.
- No dividends were paid or declared during the period.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Cosmo Metals Limited (CMO) ORDINARY FULLY PAID |
Materials |
$2 |
Letter to Shareholders - Notice of GM
|
26 Feb 2025 2:31PM |
$0.022 |
$0.015 |
fallen by
31.82%
|
|
JB Hi-Fi Limited (JBH) ORDINARY FULLY PAID |
Consumer Discretionary |
$9,627 |
Update - Dividend/Distribution - JBH
|
26 Feb 2025 2:30PM |
$91.355 |
$88.050 |
fallen by
3.62%
|
|
Cosmo Metals Limited (CMO) ORDINARY FULLY PAID |
Materials |
$2 |
Notice of General Meeting/Proxy Form
|
26 Feb 2025 2:30PM |
$0.022 |
$0.015 |
fallen by
31.82%
|
|
Sparc Technologies Limited (SPN) ORDINARY FULLY PAID |
Materials |
$19 |
Appendix 4D and Half Yearly Report and Accounts
|
26 Feb 2025 2:28PM |
$0.205 |
$0.203 |
fallen by
1.22%
|
|
SPN - Price-sensitive ASX Announcement
Full Release
Key Points
- Sparc Technologies recorded a loss after tax of $802,190 for the half-year ended 31 December 2024.
- Loss reduced compared to $2,058,806 for the same period in 2023.
- The company focuses on research and development of innovative technologies.
- No dividends were paid or recommended during the half-year.
- Working capital decreased to $1,609,205 from $3,035,073 in the previous year.
- The group experienced negative cash flows from operating activities amounting to $399,876.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Mayur Resources Limited (MRL) CHESS DEPOSITARY INTERESTS 1:1 |
Materials |
$173 |
Application for quotation of securities - MRL
|
26 Feb 2025 2:28PM |
$0.295 |
$0.325 |
risen by
10.17%
|
|
Prophecy International Holdings Limited (PRO) ORDINARY FULLY PAID |
Information Technology |
$33 |
Half Year Accounts
|
26 Feb 2025 2:24PM |
$0.480 |
$0.450 |
fallen by
6.25%
|
|
PRO - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue increased to $11.6 million in H1 FY25, up 1% year-on-year.
- Contracted annualised recurring revenue (ARR) reached $25.9 million.
- Company focused on organic growth through emite and Snare product lines.
- Transition towards subscription-based revenue model for Snare continued.
- Increased cash consumption due to investments in product development.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.